Lv et al., 2020 - Google Patents
A 5-fluorouracil–kaempferol drug–drug cocrystal: a ternary phase diagram, characterization and property evaluationLv et al., 2020
- Document ID
- 2003835199262998957
- Author
- Lv W
- Liu X
- Dai X
- Long X
- Chen J
- Publication year
- Publication venue
- CrystEngComm
External Links
Snippet
The synergistic anti-tumor effect of a typical chemotherapy drug, 5-fluorouracil, and a natural flavonoid compound, kaempferol, has been reported recently. However, the oral absorption of 5-fluorouracil is incomplete and nonuniform for different individuals due to fast metabolism …
- 239000003814 drug 0 title abstract description 28
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P-C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lv et al. | A 5-fluorouracil–kaempferol drug–drug cocrystal: a ternary phase diagram, characterization and property evaluation | |
| JP7134294B2 (en) | Pharmaceutically acceptable salts of β-guanidinopropionic acid with improved properties and uses thereof | |
| He et al. | Polymorphism observed in dapsone–flavone cocrystals that present pronounced differences in solubility and stability | |
| Sarmah et al. | Mechanochemical synthesis of drug–drug and drug–nutraceutical multicomponent solids of olanzapine | |
| KR102432526B1 (en) | Method for preparing dicycloplatin | |
| CN108558835B (en) | Crystal form, preparation method and application of deuterated AZD9291 | |
| MX2014015623A (en) | Crystalline form i of tyrosine kinase inhibitor dimaleate and preparation methods thereof. | |
| JP6717947B2 (en) | Crystals of quinazoline derivative and preparation method thereof | |
| Ren et al. | Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior | |
| Jia et al. | Cocrystals of regorafenib with dicarboxylic acids: Synthesis, characterization and property evaluation | |
| WO2016079313A1 (en) | Crystalline forms of afatinib dimaleate | |
| Wang et al. | Cocrystallization of lenvatinib and temozolomide to improve the performance in terms of stability, dissolution, and tabletability | |
| Zou et al. | Gefitinib salts/cocrystals with phenolic acids as a promising solid-state approach to improve solubility | |
| JP6674027B2 (en) | Crystal of quinazoline derivative and method for preparing the same | |
| WO2019205909A1 (en) | Eutectic crystal of temozolomide and baicalein and preparation method therefor | |
| US11111234B2 (en) | Salt of a quinazoline derivative-like tyrosine kinase inhibitor and crystal form thereof | |
| Zhang et al. | A novel drug–drug cocrystal of tegafur and myricetin: optimized properties of dissolution and tabletability | |
| Allu et al. | Improving Dissolution Rate and Solubility of Palbociclib Salts/Cocrystal for Anticancer Efficacy | |
| JP2024535857A (en) | Pharmaceutically acceptable salts and crystals of fused bicyclic derivatives and their preparation methods | |
| EP3740492B1 (en) | 1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,3'-dione compounds as therapeutic agents activating tp53 | |
| He et al. | Preparation and solid-state characterization of two novel berberine chloride cocrystals with benzene derivatives | |
| Ujam et al. | Crystal structure of 4-hydroxy-6-methyl-3-[(1 E)-1-(2-phenylhydrazinylidene) ethyl]-2 H-pyran-2-one | |
| Wu et al. | Salts of rucaparib with dicarboxylic acids: synthesis, crystal structures and solubility | |
| TW202430157A (en) | Solid form of fused ring compound, preparation method and use thereof | |
| CN112898168A (en) | Salt of 2-hydroxybenzylamine-succinic acid and preparation method thereof |